Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Knowing when to choose investing over saving can significantly enhance your wealth. Discover strategies to make informed financial decisions.
23,985 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Nvidia could be headed toward a $300 stock price as AI demand, margins, and strategic bets align. This article breaks...
Verizon is shrinking its footprint and workforce as it pivots to a franchise-based retail model and tighter costs. Th...
Shares FISERV rising today can reflect more than a quick swing. This article breaks down the catalysts, the business ...
Mega-cap tech values are under pressure, and the question on many minds is whether Alphabet, Apple, Microsoft kicked ...
A jailed crypto founder weighs in on a high-stakes regulatory bill, and senators from both parties push back. The cla...
Viking Holdings (VIK) 2025 reveals how the company navigated a mixed year. This analysis breaks down Q4 results, marg...
Zscaler is steering its platform toward AI-driven security, aiming to reshape enterprise defense and investor returns...
A landmark Nvidia-backed investment could be a game changer for Nebius shareholders. This in-depth look breaks down w...
Alphabet's enormous $346 investment portfolio is quietly powering profits beyond AI hype. This article explains where...
A surge of optimism surrounds NVIDIA's latest driverless advances and what they mean for Uber stock investors. This p...
A high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...